Business Context and Reporting Period
This Form 8-K is a current report filed by Reneo Pharmaceuticals, Inc. (not Onkure Therapeutics, Inc.) on August 11, 2021. The filing serves to announce the Company's financial results for the quarter ended June 30, 2021, along with other recent corporate updates. The Company is an emerging growth company incorporated in Delaware, with its common stock (RPHM) trading on The Nasdaq Stock Market LLC.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The actual financial data is contained in the press release furnished as Exhibit 99.1, which is referenced but not included in the input text.
Material Changes
The filing indicates that the Company issued a press release reporting financial results for the quarter ended June 30, 2021. However, the text does not detail specific material changes, variances, or comparisons to prior periods. Investors must refer to Exhibit 99.1 for these details.
Guidance, Outlook, and Risks
The filing mentions "other recent corporate updates" in the press release but does not provide specific guidance, outlook, management commentary, risks, or contingencies within the text provided. The information in Item 2.02 is explicitly stated as "furnished" and not "filed" for purposes of liability under the Securities Exchange Act of 1934.
Important Facts for Investor Verification
- Company Identity: Verify that the filing pertains to Reneo Pharmaceuticals, Inc. (RPHM), as the request metadata incorrectly identified the company as Onkure Therapeutics, Inc.
- Missing Data: Confirm that specific financial metrics (revenue, net loss, cash position) are absent from this summary and must be retrieved from the attached Exhibit 99.1 (Press Release).
- Legal Status: Note that the financial information in this 8-K is furnished and not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
- Reporting Period: The results cover the quarter ended June 30, 2021.